| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929553A1 Pyrimidine derivatives and processes for the preparation thereof |
| 07/21/1999 | EP0929544A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929537A1 Troponyl piperazines as selective dopamine d4 receptor ligands |
| 07/21/1999 | EP0929533A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929529A2 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed et a?/et b? endothelin receptor antagonists |
| 07/21/1999 | EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/21/1999 | EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 07/21/1999 | EP0929517A1 Hydroxamic acid derivatives |
| 07/21/1999 | EP0929311A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 07/21/1999 | EP0929299A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS |
| 07/21/1999 | EP0929218A2 P2y receptor antagonists |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223664A Serine protease inhibitors |
| 07/21/1999 | CN1223654A N-[4-(heteroarylmethyl) phenyl]-heteroarylamines |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223643A Prenyl transferase inhibitors |
| 07/21/1999 | CN1223642A Inhibitors of prenyl transferases |
| 07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/21/1999 | CN1223582A Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 07/21/1999 | CN1223140A Health care food and production method thereof |
| 07/21/1999 | CN1044249C Matrix metalloprotease inhibitors |
| 07/21/1999 | CN1044247C Penicillic olefin derivant and preparation process and use thereof |
| 07/21/1999 | CN1044244C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity |
| 07/21/1999 | CN1044242C Heterocyclic-cyclic amine derivatives |
| 07/21/1999 | CN1044234C Substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925768 Antiinflammatory agents; analgesics, anticoagulants, narcotics |
| 07/20/1999 | US5925742 Protein affecting KATP channels |
| 07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925684 Stable oil in water emulsion containing carotenoid, ethylene oxide-propylene oxide block copolymer emulsifier |
| 07/20/1999 | US5925683 Liquid embolic agents |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925661 Nervous system disorders |
| 07/20/1999 | US5925660 Enzyme inhibitors for phosphatase |
| 07/20/1999 | US5925654 Antiinflammatory agents and enzyme inhibitors |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925627 Use of NK-1 receptor antagonists for treating movement disorders |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925536 Receptor-type phosphotyrosine phosphatase-β |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925382 Antioxidant composition and method for production thereof |
| 07/20/1999 | US5925357 Extracts of plants |
| 07/20/1999 | US5925354 Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| 07/20/1999 | CA2158036C 3,4-diarylchromans for treatment of dermatitis |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA2024419C Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them |
| 07/20/1999 | CA2007200C 2-aminopyrimidinone derivatives |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/20/1999 | CA1340657C Modulateurs de la proteine kinase c |
| 07/16/1999 | CA2258454A1 Benzosulfone derivatives |
| 07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
| 07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035161A1 Process for preparing carboxamido-4-azasteroids |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035150A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f |
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035144A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | WO1999035131A1 Aryl fused azapolycyclic compounds |
| 07/15/1999 | WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999035123A1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 07/15/1999 | WO1999034822A1 Formulations for amylin agonist peptides |
| 07/15/1999 | WO1999034806A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA) |
| 07/15/1999 | WO1999034804A1 A2a adenosine receptor agonists |
| 07/15/1999 | WO1999034786A2 Lipase inhibiting polymers |
| 07/15/1999 | WO1999034785A2 Treatment of dyskinesias |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034783A1 USE OF PPAR-η ACTIVATORS IN DERMATOLOGY |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034680A1 Decorated red blood cells |
| 07/15/1999 | WO1999024026A3 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | CA2365742A1 Formulations for amylin agonist peptides |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2324972A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318416A1 Polymers comprising lipase inhibiting groups |